Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Oncotarget|November 17, 2016
Disrupted in schizophrenia 1 (DISC1) inhibits glioblastoma development by regulating mitochondria dynamicsXingchun Gao, Yajing Mi, Na Guo, et al.
Theranostics|April 25, 2017
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell CarcinomaMinglei Wang, Xuefeng Li, Jin Zhang, et al.
Oncotarget|February 9, 2018
SOX9-PDK1 axis is essential for glioma stem cell self-renewal and temozolomide resistanceZhen Wang, Xiaoshan Xu, Nan Liu, et al.
Plos One|December 9, 2017
Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathwayHui Liu, Nan Liu, Yingduan Cheng, et al.
Frontiers in Endocrinology|December 21, 2020
Virus Injection to the Pituitary <i>via</i> Transsphenoidal Approach and the Innervation of Anterior and Posterior Pituitary of RatXiaohui Li, Shanchun Su, Haiwen Zhao, et al.
NPJ Science of Food|September 6, 2024
A probiotic Limosilactobacillus fermentum GR-3 mitigates colitis-associated tumorigenesis in mice via modulating gut microbiomeTuoyu Zhou, Jingyuan Wu, Aman Khan, et al.
ACS Nano|May 4, 2018
Mimicking Pathogenic Invasion with the Complexes of Au<sub>22</sub>(SG)<sub>18</sub>-Engineered Assemblies and Folic AcidChunlei Zhang, Amin Zhang, Wenxiu Hou, et al.
American Journal of Translational Research|July 12, 2016
Birth of MTH1 as a therapeutic target for glioblastoma: MTH1 is indispensable for gliomatumorigenesisYanyang Tu, Zhen Wang, Xin Wang, et al.
Life Sciences|April 26, 2023
Tumor-targeting engineered probiotic Escherichia coli Nissle 1917 inhibits colorectal tumorigenesis and modulates gut microbiota homeostasis in miceHaibo Tang, Tuoyu Zhou, Weilin Jin, et al.
Biomaterials|February 5, 2023
Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatmentYeying Wang, Yang Liu, Yi Liu, et al.
Pageof 8